We too observed the acquisition of biallelic deletion of CDKN2A (a reflection of tumor progression) in the nodal metastasis of at least 2 patients in whom the primary tumors retained both copies of the gene (Table S3), but neither patient developed extranodal metastasis in follow-up. Here, CDKN2A is linked to neoplasm.